S5 Ep37: Sekeres Previews Potential Combination Strategies in HR-MDS
OncLive® On Air - En podcast av OncLive® On Air
Dr. Sekeres discusses the current unmet needs of patients with higher-risk myelodysplastic syndromes receiving hypomethylating agents, the potential utility of novel combinations in development, and the incorporation of other end points beyond overall survival in clinical trials.
